Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An extremely rare syndrome which is characterized by hypoplastic amelogenesis imperfecta (hypoplastic dental enamel) and nephrocalcinosis (precipitation of calcium salts in renal tissue). Oral manifestations include yellow and misshaped teeth, delayed tooth eruption, and intrapulpal calcifications. Nephrocalcinosis is often asymptomatic but can progress during late childhood or early adulthood to impaired renal function (e.g. recurrent urinary infections and renal tubular acidosis), and rarely to end-stage renal failure.
Features include always present findings: Amelogenesis imperfecta, Gingival fibromatosis, and Delayed eruption of permanent teeth. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 3 | Nephrocalcinosis, Reduced kidney function (renal insufficiency), Impaired renal concentrating ability |
FAM20A encodes FAM20A golgi associated secretory pathway pseudokinase (541 aa). Pseudokinase that acts as an allosteric activator of the Golgi serine/threonine protein kinase FAM20C and is involved in biomineralization of teeth. Highest expression in Cervix Endocervix (52.9 TPM) and Liver (44.6 TPM).
Amelogenesis imperfecta type 1G is associated with mutations in the FAM20A gene on chromosome 17.
FAM20A is classified as a druggable target (Druggable Genome, Kinase, and Serine Threonine Kinase categories) with score 0.0.
Genetic testing for FAM20A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for amelogenesis imperfecta type 1G has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
18 publications have been identified in PubMed for amelogenesis imperfecta type 1G. Research spans Basic Science / Preclinical (28%), Review / Meta-Analysis (22%), and Case Report / Case Series (22%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 28% |
Research summaries | 4 | 22% |
Patient case studies | 4 | 22% |
Other research | 2 | 11% |
Disease patterns and progression | 2 | 11% |
Testing and diagnosis research | 1 | 6% |
Ullah S (2026). [PMID: 40108106](https://pubmed.ncbi.nlm.nih.gov/40108106/). *Biochem Genet*. [Case Report / Case Series]
Sriwattanapong K (2026). [PMID: 40693438](https://pubmed.ncbi.nlm.nih.gov/40693438/). *Cell Prolif*. [Basic Science / Preclinical]
Koul R (2025). [PMID: 39872188](https://pubmed.ncbi.nlm.nih.gov/39872188/). *Med J Armed Forces India*. [Review / Meta-Analysis]
Baker A (2025). [PMID: 41241263](https://pubmed.ncbi.nlm.nih.gov/41241263/). *Matrix Biol*. [Review / Meta-Analysis]
Besa-Witto C (2025). [PMID: 39777984](https://pubmed.ncbi.nlm.nih.gov/39777984/). *Oral Dis*. [Epidemiology / Natural History]
Tay JRH (2025). [PMID: 40719752](https://pubmed.ncbi.nlm.nih.gov/40719752/). *Clin Adv Periodontics*. [Case Report / Case Series]
Hany U (2025). [PMID: 40741335](https://pubmed.ncbi.nlm.nih.gov/40741335/). *Hum Mutat*. [Diagnostic / Biomarker]
Sharmin N (2025). [PMID: 40569950](https://pubmed.ncbi.nlm.nih.gov/40569950/). *PLoS One*. [Basic Science / Preclinical]
Roomaney IA (2025). [PMID: 40089179](https://pubmed.ncbi.nlm.nih.gov/40089179/). *Eur J Med Genet*. [Review / Meta-Analysis]
Erkapers M (2024). [PMID: 39376587](https://pubmed.ncbi.nlm.nih.gov/39376587/). *Ups J Med Sci*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 10:16 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center